Since 2020, when the UN reclassified cannabis in the list of narcotics from Schedule I (prohibited substance) to Schedule IV

Chief Executive Officer of Linneo Health, Don Bellamy, and Regulatory Affairs Director, María Ángeles Muñoz Marín share insights from this

Last year we shared the experience of our first intern, Mónica Muñoz, who provided an insight into her time at

1. Can you tell us about your background and what led you to the pharmaceutical industry? My first interest in

1.Can you give me some background on how Linneo Health got involved in the cannabis industry? Linneo is an independent

By Marta Mora, Environmental Officer, Linneo Health Despite its relatively young age, the cannabis industry, particularly those involved in the